VentriPoint Diagnostics Receives CE Mark for Its NRV™ Application
4/17/2013 7:50:26 AM
More...
|
VentriPoint Diagnostics Receives FDA Clearance for Pulmonary Arterial Hypertension
3/1/2013 8:11:40 AM
More...
|
VentriPoint Diagnostics Joins OTCQX
3/28/2012 11:04:56 AM
More...
|
VentriPoint Diagnostics Announces Appointment of Dr. George Adams as President, CEO and Director, Proposed Private Placement and Other Matters
9/22/2010 7:44:50 AM
More...
|
VentriPoint Diagnostics Announces Installation of Its VMS 3D Cardiac Technology in Toronto's Hospital For Sick Children
6/2/2010 10:11:06 AM
More...
|
VentriPoint Diagnostics to Present Clinical Validation Study at American College of Cardiology 59th Annual Scientific Session in March
1/27/2010 2:15:43 PM
More...
|
VentriPoint Diagnostics Announces European CE Mark Approval of Critical Cardiac Diagnostic System
12/10/2009 6:27:09 AM
More...
|
VentriPoint Diagnostics Secures $1 Million Bridge Loan to Support Beta Trials
10/20/2008 11:02:52 AM
More...
|
VentriPoint Diagnostics Engages CHF Investor Relations and Reports Approval of Shares Issued to Directors and Consultants as Payment for Services
10/3/2008 9:41:26 AM
More...
|
VentriPoint Diagnostics Engages CHF Investor Relations and Reports Approval of Shares Issued to Directors and Consultants as Payment for Services
10/2/2008 4:38:02 PM
More...
|
|